ertapenem has been researched along with Pneumonia, Pneumococcal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cambronero-Hernandez, E; Carides, A; Isaacs, R; Oliveria, T; Rohlf, J; Simon, S; Vetter, N | 1 |
| Friedland, IR; Isaacs, RD; McCarroll, KA; Woods, GL | 1 |
| Allouch, P; Decousser, JW; Methlouthi, I; Pina, P | 1 |
| Bishai, WR; Helke, K; Nuermberger, E | 1 |
| Bast, DJ; De Azavedo, JC; Dresser, L; Duncan, CL; Low, DE; Walker, SE | 1 |
2 trial(s) available for ertapenem and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Ertapenem; Europe; Female; Hospitalization; Humans; Injections, Intramuscular; Injections, Intravenous; Lactams; Latin America; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome; United States | 2002 |
Ertapenem therapy for community-acquired pneumonia in the elderly.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Logistic Models; Male; Odds Ratio; Pneumonia, Pneumococcal; Retrospective Studies; Statistics, Nonparametric; Streptococcus pneumoniae; Treatment Outcome | 2003 |
3 other study(ies) available for ertapenem and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2005 |
Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy.
Topics: Aerosols; Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; Drug Resistance, Bacterial; Ertapenem; Female; Mice; Mice, Inbred CBA; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2005 |
Antipneumococcal activity of ertapenem compared with gatifloxacin in a temperature-sensitive murine model of acute pneumonia.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; DNA Topoisomerase IV; Ertapenem; Fluoroquinolones; Gatifloxacin; Mice; Mice, Inbred Strains; Mutation; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Temperature; Treatment Outcome | 2007 |